Active, Not Recruiting
Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors
NCT05334329
- Conditions
- Advanced Lung Non-Small Cell Carcinoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
- Locations
-
- Chao Family Comprehensive Cancer Center University of California, Irvine Orange, California, United States